![1]()
News
No serious CV risks for elderly after Pfizer COVID-19 vaccine
December 2, 2021
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals.
News
No short-term death risk in elderly after COVID-19 vaccines
October 13, 2021
Early reports of deaths shortly after mRNA-based vaccination of very frail elderly patients in Norway prompted a nationwide safety study.
News
Omega-3s tame inflammation in elderly COVID-19 patients
October 13, 2021
Those who received an intravenous infusion had significant decreases from baseline to end of treatment in the neutrophil-to-lymphocyte ratio.
News
Nutritional support may be lifesaving in heart failure
May 6, 2021
Patients with high-risk chronic heart failure given individualized nutritional support in-hospital had lower mortality following discharge, a new analysis shows.
News
COVID-19 virus reinfections rare; riskiest after age 65
March 19, 2021
Initial infection was associated with about 80% protection overall against getting SARS-CoV-2 again.
![1]()
News
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
March 11, 2021
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.
![1]()
News
BMI, age, and sex affect COVID-19 vaccine antibody response
March 5, 2021
Study finds that older and heavier men have lower antibody responses to the Pfizer mRNA vaccine than do younger, leaner, and female recipients.
![1]()
News
Neurologic disorders ubiquitous and rising in the U.S.
March 2, 2021
Most of the rise in disease burden could be attributed to population aging, while age-standardized figures showed stroke and dementias to be level or declining, offering hope that prevention measures may be having an effect.
News
COVID-19 vaccination linked to less mechanical ventilation
March 1, 2021
A new paper offers a “real-world” look at vaccination effectiveness, according to the authors.
News
Early use of high-titer plasma may prevent severe COVID-19
January 7, 2021
Administering convalescent plasma that has high levels of antibodies against SARS-CoV-2 within the first 3 days of symptoms was associated with significantly lower chances of progression to severe COVID-19, new evidence demonstrates.
